## Abstract The __E‐cadherin__ (__CDH1__) gene has been associated with prostate carcinogenesis. The C/A polymorphism −160 base pairs relative to the transcription start site has been shown to decrease gene transcription. We analyzed the association between this polymorphism and the risk of sporadi
Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer
✍ Scribed by Bas A.J. Verhage; Kjeld van Houwelingen; T. Emiel G. Ruijter; Lambertus A. Kiemeney; Jack A. Schalken
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 103 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
E-cadherin plays a major role in intercellular adhesion, cell polarity and tissue architecture. We determined the relative risk of PCa associated with a previously reported C/A SNP at -160 bp relative to the transcription-start site of the E-cadherin gene promoter. Eighty-two PCa patients and 188 controls were genotyped. Genotype and allele frequencies differed significantly among cases and controls. A-allele carriers had a higher relative risk of PCa (OR = 3.6, 95% CI 2.0-6.4) compared to C-only carriers. AC and AA genotypes had an increased risk of PCa (OR = 3.8, 95% CI 2.1-6.8 and OR = 1.7, 95% CI 0.4-6.6, respectively) compared to CC genotypes.
📜 SIMILAR VOLUMES
## Abstract ## Background and Objectives Hepatocellular carcinoma (HCC) is one of the most frequent malignant neoplasms worldwide, and is the second leading cause of cancer death in Taiwan. E‐cadherin is an epithelial cell adhesion molecule, and decreased E‐cadherin expression in HCC is associated
## Abstract We investigated effects on oral cancer (OC) risk of an interaction between a single nucleotide polymorphism (SNP) in the alcohol dehydrogenase 3 (ADH~3~) gene and alcohol consumption levels using a hospital‐based study of 93 cases and 99 controls conducted in Athens, Greece. This SNP af
## Abstract Mutations within the __FLT3__ gene are of growing importance for classification, risk assessment, and therapeutic targeting of acute myeloid leukemia (AML). We analyzed 656 AML patients for a recently described single‐nucleotide polymorphism (SNP) in the third immunoglobulin‐like domain